Back to discover
Drug

Norepinephrine

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as (-)-arterenol, (-)-noradrenaline, (R)-(-)-norepinephrine, (R)-noradrenaline+15 more

(-)-arterenol, (-)-noradrenaline, (R)-(-)-norepinephrine, (R)-noradrenaline, (R)-norepinephrine, Arterenol, L-Norepinephrine, L-noradrenaline, Levophed, Nor-adrenaline, Noradrenalin, Noradrenaline, Norepinefrina, (-)-norepinephrine, Norépinéphrine, (R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol, Levophed Bitartrate, Norepinephrine Bitartrate, Norepinephrinum.

9
Research papers
36
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

Hot Flashes and Neurovascular Function in Women

Clinical trial2026-06-12Results expected Q4 2026 · ClinicalTrials.gov

Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus.

Research2023-07-24Proceedings of the National Academy of Sciences of the United States of America

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Norepinephrine
Aliases & brands
(-)-arterenol(-)-noradrenaline(R)-(-)-norepinephrine(R)-noradrenaline(R)-norepinephrineArterenolL-NorepinephrineL-noradrenalineLevophedNor-adrenalineNoradrenalinNoradrenalineNorepinefrina(-)-norepinephrineNorépinéphrine(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediolLevophed BitartrateNorepinephrine BitartrateNorepinephrinum
RxNorm CUI
7512
ChEMBL ID
CHEMBL1437
ATC codes
C01CA03
UNII
X4W3ENH1CV

Clinical trials

170 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
170
registered trials across all phases
LATEST COMPLETION 2026
36
Active studies
32
Recruiting
151
Late-stage (III+)
87
Completed
47
Discontinued
PHASE DISTRIBUTIONn = 170
Early Phase 17Phase 12Phase 1 / 23Phase 27Phase 2 / 36Phase 325Phase 451Phase N / A69

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

9 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20002024
Most influential

Gender differences in depression. Critical review.

The British journal of psychiatry : the journal of mental science · 2000 · 1,163 cites

Central modulation of pain.

The Journal of clinical investigation · 2010 · 781 cites
Recent papers
Major research themes8
Norepinephrine2Attention1Decision Making1Endotoxemia1Galanin1Glucagon-Like Peptide 11Glucagon-Like Peptide-1 Receptor1Insulin Secretion1
Journals, researchers & institutions
Top journals
  • Nature communications2
  • Frontiers in immunology1
  • Journal of neuroinflammation1
  • Proceedings of the National Academy of Sciences of the United States of America1
  • Psychological bulletin1
  • The Behavioral and brain sciences1
Leading researchers
  • Al-Abed Y1
  • Aston-Jones G1
  • Bartels B1
  • Brierley DI1
  • Broichhagen J1
  • Caramia M1
  • Clewett D1
  • Cohen JD1
Leading institutions
free-text, unnormalised
  • Baylor College of Medicine1
  • Beijing Key Laboratory of Neural Regeneration and Repair1
  • Case Western Reserve University1
  • Center for Brain Research1
  • Centre for Cardiovascular and Metabolic Neuroscience1
  • Columbia University1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 2 of the same disease areas as Norepinephrine in the shared literature.

2 shared diseases1 shared paper

Studied across 2 of the same disease areas as Norepinephrine in the shared literature.

2 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials